Home/Filings/4/0001179110-21-002560
4//SEC Filing

Sun Elaine D 4

Accession 0001179110-21-002560

CIK 0001159036other

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 7:15 PM ET

Size

8.4 KB

Accession

0001179110-21-002560

Insider Transaction Report

Form 4
Period: 2021-03-02
Sun Elaine D
SVP, Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2021-03-02+12,16612,166 total
  • Tax Payment

    Common Stock

    2021-03-02$45.01/sh4,285$192,8687,881 total
  • Exercise/Conversion

    Restricted Stock Units

    2021-03-0212,16636,496 total
    Exercise: $0.00Common Stock (12,166 underlying)
Footnotes (2)
  • [F1]The reported disposition of 4,285 shares represents the shares that were withheld by the issuer as payment for minimum statutory tax withholding obligations.
  • [F2]This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.

Issuer

HALOZYME THERAPEUTICS, INC.

CIK 0001159036

Entity typeother

Related Parties

1
  • filerCIK 0001805339

Filing Metadata

Form type
4
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 7:15 PM ET
Size
8.4 KB